Skip to main content

Resultados relacionados

Resultados totales (Incluyendo duplicados): 6
Encontrada(s) 1 página(s)

Repositorio Digital de la UPF
Publication Artículo científico (JournalArticle)

Inclusion of a specific T cell epitope increases the protection conferred against foot-and-mouth disease virus in pigs by a linear peptide containing an immunodominant B cell site

  • Cubillos, Carolina
  • García de la Torre, Beatriz
  • Bárcena, Juan
  • Andreu Martínez, David
  • Sobrino, Francisco
  • Blanco, Esther
Background: Foot-and-mouth disease virus (FMDV) causes an economically important and highly contagious disease of cloven-hoofed animals. FMD control in endemic regions is implemented using chemically inactivated whole-virus vaccines. Currently, efforts are directed to the development of safe and marked vaccines. We have previously reported solid protection against FMDV conferred by branched structures (dendrimeric peptides) harbouring virus-specific B and T-cell epitopes. In order to gain insights into the factors determining a protective immune response against FMDV, in this report we sought to dissect the immunogenicity conferred by different peptide-based immunogens. Thus, we have assessed the immune response and protection elicited in pigs by linear peptides harbouring the same FMDV B-cell or B and T-cell epitopes (B and TB peptides, respectively). Results: Pigs were twice immunized with either the B-cell epitope (site A) peptide or with TB, a peptide where the B-cell epitope was in tandem with the T-cell epitope [3A (21-35)]. Both, B and TB peptides were able to induce specific humoral (including neutralizing antibodies) and cellular immune responses against FMDV, but did not afford full protection in pigs. The data obtained showed that the T-cell epitope used is capable to induce efficient T-cell priming that contributes to improve the protection against FMDV. However, the IgA titres and IFNγ release elicited by these linear peptides were lower than those detected previously with the dendrimeric peptides. Conclusions: We conclude that the incorporation of a FMDV specific T-cell epitope in the peptide formulation allows a significant reduction in virus excretion and clinical score after challenge. However, the linear TB peptide did not afford full protection in challenged pigs, as that previously reported using the dendrimeric construction indicating that, besides the inclusion of an adecuate T-cell epitope in the formulation, an efficient presentation of the B-cell epitope is crucial to elicit full protection by peptide vaccines., Work at CBMSO and INIA was supported by Spanish grants from CICYT (BIO2008-0447-C03-01 and AGL2010-22200-C02-02), MEC (PORCIVIR, CSD2006-0007), Fundación Ramón Areces and by EU Network of Excellence, EPIZONE (ContractNoFOODCT-2006-016236). Work at UPF was supported by the Spanish Ministry of Education and Science (grant BIO2002-04091-C03-01 and BIO2005-07592-CO2-02) and by Generalitat de Catalunya (SGR00494 and CIDEM-BAPP)
Repositorio Digital de la UPF
Publication Artículo científico (JournalArticle)

Therapeutic Index of Gramicidin S is Strongly Modulated by d-Phenylalanine Analogues at the β-Turn

  • Solanas, Concepción
  • Torre, Beatriz G. de la
  • Fernández Reyes, María
  • Santiveri, Clara M.
  • Jiménez, M. Ángeles
  • Rivas, Luis
  • Jiménez, Ana I.
  • Andreu Martínez, David
  • Cativiela, Carlos
Analogues of the cationic antimicrobial peptide gramicidin S (GS), cyclo(Val-Orn-Leu-D-Phe-Pro)2, with d-Phe residues replaced by different (restricted mobility, mostly) surrogates have been synthesized and used in SAR studies against several pathogenic bacteria. While all D-Phe substitutions are shown by NMR to preserve the overall beta-sheet conformation, they entail subtle structural alterations that lead to significant modifications in biological activity. In particular, the analogue incorporating D-Tic (1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid) shows a modest but significant increase in therapeutic index, mostly due to a sharp decrease in hemolytic effect. The fact that NMR data show a shortened distance between the D-Tic aromatic ring and the Orn delta-amino group may help explain the improved antibiotic profile of this analogue., This work was supported by Ministerio de Educación y Ciencia (BIO2005-07592-CO2-02 to D.A., BFU2005-01855 and CTQ2008-0080 to M.A.J., CTQ2007-62245 to C.C.), Fondo de Investigaciones Sanitarias (PI061125 and RD 06/0021/0006 to L.R., PI040885 to D.A.), by the regional governments of Aragón (research group E40), Catalunya (SGR2005-00494), and Madrid (S-BIO-0260/2006).
Repositorio Digital de la UPF
Publication Artículo científico (JournalArticle)

The C-terminus of H-ras as a target for the covalent binding of reactive compounds modulating Ras-dependent pathways

  • Oeste, Clara L.
  • Díez Dacal, Beatriz
  • Bray, Francesca
  • García de Lacoba, Mario
  • Torre, Beatriz G. de la
  • Andreu Martínez, David
  • Ruiz Sánchez, Antonio J
  • Pérez Inestrosa, Ezequiel
  • García Domínguez, Carlota A
  • Rojas, José M
  • Pérez Sala, Dolores
Ras proteins are crucial players in differentiation and oncogenesis and constitute important drug targets. The localization and activity of Ras proteins are highly dependent on posttranslational modifications at their C-termini. In addition to an isoprenylated cysteine, H-Ras, but not other Ras proteins, possesses two cysteine residues (C181 and C184) in the C-terminal hypervariable domain that act as palmitoylation sites in cells. Cyclopentenone prostaglandins (cyPG) are reactive lipidic mediators that covalently bind to H-Ras and activate H-Ras dependent pathways. Dienone cyPG, such as 15-deoxy-Δ12,14-PGJ2 (15d-PGJ2) and Δ12-PGJ2 selectively bind to the H-Ras hypervariable domain. Here we show that these cyPG bind simultaneously C181 and C184 of H-Ras, thus potentially altering the conformational tendencies of the hypervariable domain. Based on these results, we have explored the capacity of several bifunctional cysteine reactive small molecules to bind to the hypervariable domain of H-Ras proteins. Interestingly, phenylarsine oxide (PAO), a widely used tyrosine phosphatase inhibitor, and dibromobimane, a cross-linking agent used for cysteine mapping, effectively bind H-Ras hypervariable domain. The interaction of PAO with H-Ras takes place in vitro and in cells and blocks modification of H-Ras by 15d-PGJ2. Moreover, PAO treatment selectively alters H-Ras membrane partition and the pattern of H-Ras activation in cells, from the plasma membrane to endomembranes. These results identify H-Ras as a novel target for PAO. More importantly, these observations reveal that small molecules or reactive intermediates interacting with spatially vicinal cysteines induce intramolecular cross-linking of H-Ras C-terminus potentially contributing to the modulation of Ras-dependent pathways., This work was supported by European Union Cooperation in the field of Scientific and Technical research (COST) Action CM1001, grant SAF2009-11642 from Ministerio de Ciencia e Innovación and Red Temática de Investigación Cooperativa from Instituto de Salud Carlos II (Spain) RD07/0064/0007 to DP-S and RD07/0064/0000 to EP-I. Work at Universitat Pompeu Fabra was supported by grants BIO2005-07592-CO2-02 and BIO2008-04487-CO3-02 from Ministerio de Ciencia e Innovación (Spain) to DA, and by the regional government of Catalunya (SGR2005-00494). JMR’s work is supported by Fondo de Investigaciones Sanitarias-Intrasalud (PS09/00562) and Red Temática de Investigación Cooperativa RD06/0020/0003 from Instituto de Salud Carlos III, and the Spanish Association Against Cancer (AECC). CLO is the recipient of a predoctoral fellowship from the Formación de Personal Investigador (FPI) program (Ministerio de Ciencia e Innovación, Spain, BES-2010-033718). CAG-D is the recipient of a fellowship from Fondo de Investigaciones Sanitarias-Beca de Formación en Investigación. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscrip
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

The C-terminus of H-ras as a target for the covalent binding of reactive compounds modulating Ras-dependent pathways

  • Oeste, Clara L.
  • Díez Dacal, Beatriz
  • Bray, Francesca
  • García de Lacoba, Mario
  • Torre, Beatriz G. de la
  • Andreu Martínez, David
  • Ruiz Sánchez, Antonio J
  • Pérez Inestrosa, Ezequiel
  • García Domínguez, Carlota A
  • Rojas, José M
  • Pérez Sala, Dolores
Ras proteins are crucial players in differentiation and oncogenesis and constitute important drug targets. The localization and activity of Ras proteins are highly dependent on posttranslational modifications at their C-termini. In addition to an isoprenylated cysteine, H-Ras, but not other Ras proteins, possesses two cysteine residues (C181 and C184) in the C-terminal hypervariable domain that act as palmitoylation sites in cells. Cyclopentenone prostaglandins (cyPG) are reactive lipidic mediators that covalently bind to H-Ras and activate H-Ras dependent pathways. Dienone cyPG, such as 15-deoxy-Δ12,14-PGJ2 (15d-PGJ2) and Δ12-PGJ2 selectively bind to the H-Ras hypervariable domain. Here we show that these cyPG bind simultaneously C181 and C184 of H-Ras, thus potentially altering the conformational tendencies of the hypervariable domain. Based on these results, we have explored the capacity of several bifunctional cysteine reactive small molecules to bind to the hypervariable domain of H-Ras proteins. Interestingly, phenylarsine oxide (PAO), a widely used tyrosine phosphatase inhibitor, and dibromobimane, a cross-linking agent used for cysteine mapping, effectively bind H-Ras hypervariable domain. The interaction of PAO with H-Ras takes place in vitro and in cells and blocks modification of H-Ras by 15d-PGJ2. Moreover, PAO treatment selectively alters H-Ras membrane partition and the pattern of H-Ras activation in cells, from the plasma membrane to endomembranes. These results identify H-Ras as a novel target for PAO. More importantly, these observations reveal that small molecules or reactive intermediates interacting with spatially vicinal cysteines induce intramolecular cross-linking of H-Ras C-terminus potentially contributing to the modulation of Ras-dependent pathways., This work was supported by European Union Cooperation in the field of Scientific and Technical research (COST) Action CM1001, grant SAF2009-11642 from Ministerio de Ciencia e Innovación and Red Temática de Investigación Cooperativa from Instituto de Salud Carlos II (Spain) RD07/0064/0007 to DP-S and RD07/0064/0000 to EP-I. Work at Universitat Pompeu Fabra was supported by grants BIO2005-07592-CO2-02 and BIO2008-04487-CO3-02 from Ministerio de Ciencia e Innovación (Spain) to DA, and by the regional government of Catalunya (SGR2005-00494). JMR’s work is supported by Fondo de Investigaciones Sanitarias-Intrasalud (PS09/00562) and Red Temática de Investigación Cooperativa RD06/0020/0003 from Instituto de Salud Carlos III, and the Spanish Association Against Cancer (AECC). CLO is the recipient of a predoctoral fellowship from the Formación de Personal Investigador (FPI) program (Ministerio de Ciencia e Innovación, Spain, BES-2010-033718). CAG-D is the recipient of a fellowship from Fondo de Investigaciones Sanitarias-Beca de Formación en Investigación. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscrip
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

Inclusion of a specific T cell epitope increases the protection conferred against foot-and-mouth disease virus in pigs by a linear peptide containing an immunodominant B cell site

  • Cubillos, Carolina
  • García de la Torre, Beatriz
  • Bárcena, Juan
  • Andreu Martínez, David
  • Sobrino, Francisco
  • Blanco, Esther
Background: Foot-and-mouth disease virus (FMDV) causes an economically important and highly contagious disease of cloven-hoofed animals. FMD control in endemic regions is implemented using chemically inactivated whole-virus vaccines. Currently, efforts are directed to the development of safe and marked vaccines. We have previously reported solid protection against FMDV conferred by branched structures (dendrimeric peptides) harbouring virus-specific B and T-cell epitopes. In order to gain insights into the factors determining a protective immune response against FMDV, in this report we sought to dissect the immunogenicity conferred by different peptide-based immunogens. Thus, we have assessed the immune response and protection elicited in pigs by linear peptides harbouring the same FMDV B-cell or B and T-cell epitopes (B and TB peptides, respectively). Results: Pigs were twice immunized with either the B-cell epitope (site A) peptide or with TB, a peptide where the B-cell epitope was in tandem with the T-cell epitope [3A (21-35)]. Both, B and TB peptides were able to induce specific humoral (including neutralizing antibodies) and cellular immune responses against FMDV, but did not afford full protection in pigs. The data obtained showed that the T-cell epitope used is capable to induce efficient T-cell priming that contributes to improve the protection against FMDV. However, the IgA titres and IFNγ release elicited by these linear peptides were lower than those detected previously with the dendrimeric peptides. Conclusions: We conclude that the incorporation of a FMDV specific T-cell epitope in the peptide formulation allows a significant reduction in virus excretion and clinical score after challenge. However, the linear TB peptide did not afford full protection in challenged pigs, as that previously reported using the dendrimeric construction indicating that, besides the inclusion of an adecuate T-cell epitope in the formulation, an efficient presentation of the B-cell epitope is crucial to elicit full protection by peptide vaccines., Work at CBMSO and INIA was supported by Spanish grants from CICYT (BIO2008-0447-C03-01 and AGL2010-22200-C02-02), MEC (PORCIVIR, CSD2006-0007), Fundación Ramón Areces and by EU Network of Excellence, EPIZONE (ContractNoFOODCT-2006-016236). Work at UPF was supported by the Spanish Ministry of Education and Science (grant BIO2002-04091-C03-01 and BIO2005-07592-CO2-02) and by Generalitat de Catalunya (SGR00494 and CIDEM-BAPP)
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

Therapeutic Index of Gramicidin S is Strongly Modulated by d-Phenylalanine Analogues at the β-Turn

  • Solanas, Concepción
  • Torre, Beatriz G. de la
  • Fernández Reyes, María
  • Santiveri, Clara M.
  • Jiménez, M. Ángeles
  • Rivas, Luis
  • Jiménez, Ana I.
  • Andreu Martínez, David
  • Cativiela, Carlos
Analogues of the cationic antimicrobial peptide gramicidin S (GS), cyclo(Val-Orn-Leu-D-Phe-Pro)2, with d-Phe residues replaced by different (restricted mobility, mostly) surrogates have been synthesized and used in SAR studies against several pathogenic bacteria. While all D-Phe substitutions are shown by NMR to preserve the overall beta-sheet conformation, they entail subtle structural alterations that lead to significant modifications in biological activity. In particular, the analogue incorporating D-Tic (1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid) shows a modest but significant increase in therapeutic index, mostly due to a sharp decrease in hemolytic effect. The fact that NMR data show a shortened distance between the D-Tic aromatic ring and the Orn delta-amino group may help explain the improved antibiotic profile of this analogue., This work was supported by Ministerio de Educación y Ciencia (BIO2005-07592-CO2-02 to D.A., BFU2005-01855 and CTQ2008-0080 to M.A.J., CTQ2007-62245 to C.C.), Fondo de Investigaciones Sanitarias (PI061125 and RD 06/0021/0006 to L.R., PI040885 to D.A.), by the regional governments of Aragón (research group E40), Catalunya (SGR2005-00494), and Madrid (S-BIO-0260/2006).